Huennekens Brings Deep Industry Expertise to Help Accelerate Commercialization and Market Expansion Efforts Carlsbad, Calif., July 10, 2019 — Acutus Medical today announced the appointment of Scott Huennekens as Executive Chairman of the Board of Directors. Mr.
Funding Will Accelerate Commercialization and Facilitate Global Business Development Activities CARLSBAD, Calif., June 20, 2019 – Acutus Medical today announced a $170 million financing, including a $100 million Series D equity financing and a $70 million credit facility.
SAN FRANCISCO, Calif., May 9, 2019 – Today at the 40th annual Heart Rhythm Scientific Sessions, Acutus Medical announced the agreement to acquire Rhythm Xience, Inc., and new strategic partnerships with Peerbridge Health, Cardiac Designs and MedFact. Acutus’ expanded portfolio builds on the
Global Simultaneous Electrical Activation Mapping and Precise Anatomic Chamber Imaging Allow Improved Precision and Effectiveness Carlsbad, CA., and San Francisco, CA May 7, 2019 — Acutus Medical will demonstrate important recent advancements, showcase key new products and highlight clinical
New European/Canadian Clinical Study Initiated to Evaluate the AcQMap® System During an Atrial Fibrillation Retreatment Ablation Procedure Company to Present Data at the Heart Rhythm Society’s 39th Annual Scientific Sessions FDA clearance received on additional accessory sheath catheter CARLSBAD,
Formal testing supports joint use of the two systems Positive initial clinical experience demonstrates additive benefits of technologies Commitment to robust integration of technologies to enhance ease-of-use and lab efficiency St. Louis, MO and Carlsbad, CA - May 3, 2018 Stereotaxis (OTCQX:
